Showing results (1021-1030 of 9,901) with videos related to
Sort By:
Pageof 991
Bone Marrow Transplantation|March 14, 2003
Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukaemias if complete donor chimerism can be achievedG Massenkeil, M Nagy, M Lawang, et al.Bone Marrow Transplantation|March 14, 2003
Osteosarcoma after allogeneic bone marrow transplantation. A report of four cases from the Cooperative Osteosarcoma Study Group (COSS)S S Bielack, J S Rerin, R Dickerhoff, et al.Bone Marrow Transplantation|October 17, 2003
Localized radiation increases morbidity and mortality after TBI-containing autologous stem cell transplantation in patients with lymphomaC Emmanouilides, D J Asuncion, C Wolf, et al.Bone Marrow Transplantation|October 2, 2003
Should HIV-positive patients with lymphoma be offered stem cell transplants?A Krishnan, J Zaia, S J FormanBone Marrow Transplantation|October 2, 2003
High-dose melphalan followed by radical radiotherapy for the treatment of massive plasmacytoma of the chest wallE P Das-Gupta, G M Sidra, E M Bessell, et al.Bone Marrow Transplantation|October 2, 2003
Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantationM Yanada, K Yamamoto, N Emi, et al.Bone Marrow Transplantation|October 2, 2003
Gastric emptying after autologous haemopoietic stem-cell transplantation: a prospective trialJ-E Johansson, H Abrahamsson, T EkmanBone Marrow Transplantation|October 2, 2003
Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSCF Baron, E Baudoux, P Frère, et al.Bone Marrow Transplantation|March 3, 2004
Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effectiveP Bader, H Kreyenberg, W Hoelle, et al.Bone Marrow Transplantation|March 3, 2004
A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host diseaseK B Miller, T F Roberts, G Chan, et al.Pageof 991